The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome - 10/08/11
Reprint requests: Madeleine Duvic, MD, Department of Dermatology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Suite 1452, Houston, TX 77030.Abstract |
Background |
Alopecia can be a manifestation of mycosis fungoides (MF) and Sézary syndrome (SS), but the prevalence is unknown.
Objective |
We sought to describe the clinicopathologic presentation and molecular features of alopecia in patients with MF/SS.
Methods |
A retrospective chart review of a prospectively collected MF/SS database was used to identify patients with alopecia. The National Alopecia Areata Registry was used to identify patients with self-reported cutaneous T-cell lymphoma.
Results |
Among 1550 patients with MF/SS, 38 patients with patchy, total-scalp, or universal alopecia were identified. Thirteen of 38 (34%) had patchy alopecia clinically identical to alopecia areata. Scalp biopsy specimens were available in 5 of the 13 patients. Specimens from 4 patients had atypical T lymphocytes within the follicular epithelium or epidermis, and that from two patients had a histology of follicular mucinosis. The remaining 25 of 38 (66%) patients with MF/SS included 20 with alopecia within discreet patch/plaque or follicular lesions of MF and 5 with total-body hair loss, which presented only in those with generalized erythroderma and SS.
Limitations |
This was a retrospective study done at one cancer center. Biopsy specimens of alopecia were not available for every patient.
Conclusions |
Alopecia was observed in 2.5% of patients with MF/SS, with alopecia areata–like patchy loss in 34% and alopecia within MF lesions in 66%.
Le texte complet de cet article est disponible en PDF.Key words : alopecia areata, alopecia mucinosa, autoimmune hair loss, cutaneous T-cell lymphoma, follicular mucinosis, folliculotropic mycosis fungoides
Abbreviations used : CTCL, F-MF, MF, SS
Plan
| Supported by the National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) Funded National Alopecia Registry and the Sherry L. Anderson Cutaneous T-Cell Lymphoma (CTCL) Research Fund. |
|
| Disclosure: Dr Norris declared financial relationships with Abbott and Amgen. Dr Hordinsky declared financial relationships with Novartus, Astellas, and Allergan. Ms Bi and Drs Curry, Christiano, Price, and Duvic have no conflicts of interest to declare. |
Vol 64 - N° 1
P. 53-63 - janvier 2011 Retour au numéro
Article précédent
- Staphylococcus epidermidis: A possible role in the pustules of rosacea
- Margot Whitfeld, Nishmi Gunasingam, Liang Joo Leow, Kyoko Shirato, Veronica Preda
- Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial
- Richard G. Langley, Amy S. Paller, Adelaide A. Hebert, Kara Creamer, Haoling H. Weng, Angelika Jahreis, Denise Globe, Vaishali Patel, Seth J. Orlow
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?